Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

• Wieslawa H. Dragowska ,

  * E-mail: vdragows@bccrc.ca

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Sherry A. Weppler,

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Jun Chih Wang,

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Ling Yan Wong,

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Anita I. Kapanen,

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Jenna S. Rawji,

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Corinna Warburton,

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Mohammed A. Qadir,

  Affiliation Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Elizabeth Donohue,

  Affiliation Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Michel Roberge,

  Affiliations Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada, Center for Drug Research and Development, Vancouver, British Columbia, Canada

  ⨯
• Sharon M. Gorski,

  Affiliations Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada, Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada

  ⨯
• Karen A. Gelmon,

  Affiliations Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Marcel B. Bally

  Affiliations Department of Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada, Center for Drug Research and Development, Vancouver, British Columbia, Canada, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯